Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating expenses:
Research and development		$ 20,080
General and administrative	$ 3,387	4,538
Total operating expenses	3,387	24,618
Loss from operations	(3,387)	(24,618)
Other income (expense):
Interest income	871	1,435
Other expense:	(2)	(3)
Total other income	869	1,432
Net loss	(2,518)	(23,186)
Comprehensive loss:
Net loss	(2,518)	(23,186)
Other comprehensive loss:
Unrealized (loss) gain on securities	(55)	(270)
Comprehensive loss	$ (2,573)	$ (23,456)
Net loss per share, basic	$ (0.09)	$ (0.83)
Net loss per share, diluted	$ (0.09)	$ (0.83)
Weighted-average shares of common stock outstanding, basic	28,985,019	27,795,827
Weighted-average shares of common stock outstanding, diluted	28,985,019	27,795,827